Last updated 2026-06-18
- Raised $14M funding round, Jul 2022
- Raised $1M funding round, Aug 2016
- Raised funding round, Sep 2019
Total raised
$18.5M
Last: 2022-07
Stage
Series C
Founded
2012
Headcount
9
HQ
Kiryat Ono, Israel
Sector
Health Tech & Life Sciences
About
Sanoculis offers a new alternative surgical procedure for treating glaucoma. Its Minimally Invasive Micro Sclerostomy (MIMS) solution consists of a single-patient-use sterile tool and a multi-use external machine. In the course of the surgery, a sclero-corneal drainage channel is created to reduce intraocular pressure. MIMS is a microfluidic full-thickness procedure developed as an advanced laser sclerostomy. The technique uses a cutting and drilling device to reduce trauma to the surrounding tissue, minimizing scar tissue formation and allowing for a long-lasting filtering bleb. The MIMS channel ensures a controlled fluid flow with minor complications. In March 2017, Sanoculis was granted CE marking for its MIMS device and procedure.
Funding history · 3 rounds · $18.5M total
2022-07
2019-09
Undisclosed
2016-08
$1.0M
Q&A
- What is Sanoculis's primary focus?
- Sanoculis specializes in developing a minimally invasive surgical device for glaucoma treatment, specifically its Minimally Invasive Micro Sclerostomy (MIMS) solution.
- When was Sanoculis founded?
- Sanoculis was founded in February 2012.
- What is the total amount of funding Sanoculis has raised to date?
- Sanoculis has raised a total of $18,500,000 USD.
- When was Sanoculis's most recent funding round and who were the investors?
- Sanoculis's most recent funding round occurred in July 2022, with participation from Bausch + Lomb and Eckuity.
- What is the current stage of Sanoculis's funding?
- Sanoculis is currently in its Series C funding stage.
- Who are the co-founders of Sanoculis?
- The co-founders of Sanoculis are Nir Israeli (CEO), Vadim Shmukler (CTO), and Dr. Yoseph Glovinsky (Medical Director).
- When did Sanoculis receive CE marking for its MIMS device?
- Sanoculis was granted CE marking for its MIMS device and procedure in March 2017.
Team · 3
Founder · Co-founder & Medical Director
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
SensingLaser
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
minimally-invasivesurgeryglaucomahospitalssurgeonsophthalmologymedical-deviceshealthcare-providerseye-diseasesclinicstreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | sanoculis.com |
|---|---|
| linkedin.com/company/68842608 | |
| YouTube | youtube.com/channel/UCT1KBtmpyTEvqDlwL5BG6mQ |
| Wikidata | wikidata.org/wiki/Q140045970 |
Identifiers & details
| Founded | 2012-2 |
|---|---|
| Employees (exact) | 9 |
| Wikidata QID | Q140045970 |
Radar intelligence
Patents
| EPO | 5 |
|---|
Web history (Wayback)
| Domain | sanoculis.com |
|---|
Wikidata
| QID | Q140045970 |
|---|
Certificate / subdomain footprint
| Subdomains | 4 |
|---|